(Q44305173)

English

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

restless legs syndrome

1 reference

based on heuristic

inferred from title

author name string

Heike Benes

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Wolfgang Mattern

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ines Peglau

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Tillmann Dreykluft

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Lars Bergmann

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Corinna Hansen

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ralf Kohnen

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Norbert Banik

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

S W Schoen

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Magdolna Hornyak

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

28 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

258

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1046-1054

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-010-5879-7

0 references

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

RLS epidemiology--frequencies, risk factors and methods in population studies

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Evaluating the quality of life of patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome prevalence and impact: REST general population study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Assessing health-related quality of life in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Sleep disorders and depressive feelings: a global survey with the Beck depression scale

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

The association of depression and anxiety with medical symptom burden in patients with chronic medical illness

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome as side effect of second generation antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless legs syndrome, periodic limb movements, and psychopharmacology

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Measuring depression: comparison and integration of three scales in the GENDEP study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Psychometric properties of the Medical Outcomes Study Sleep measure

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community

1 reference

https://api.crossref.org/works/10.1007%2FS00415-010-5879-7

21 January 2018

Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome, periodic limb movements in sleep, and depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in treatment-resistant depression: a 16-week pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining remission on the Montgomery-Asberg depression rating scale.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/21188406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-010-5879-7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44305173&oldid=2109313565"